TY - JOUR T1 - Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development JF - Pharmacological Reviews JO - Pharmacol Rev SP - 661 LP - 683 DO - 10.1124/pr.116.013649 VL - 70 IS - 3 AU - Colleen A. Hanlon AU - Logan T. Dowdle AU - J. Scott Henderson A2 - Nader, Michael A. Y1 - 2018/07/01 UR - http://pharmrev.aspetjournals.org/content/70/3/661.abstract N2 - Although the last 50 years of clinical and preclinical research have demonstrated that addiction is a brain disease, we still have no neural circuit–based treatments for substance dependence or cue reactivity at large. Now, for the first time, it appears that a noninvasive brain stimulation technique known as transcranial magnetic stimulation (TMS), which is Food and Drug Administration approved to treat depression, may be the first tool available to fill this critical void in addiction treatment development. The goals of this review are to 1) introduce TMS as a tool to induce causal change in behavior, cortical excitability, and frontal–striatal activity; 2) describe repetitive TMS (rTMS) as an interventional tool; 3) provide an overview of the studies that have evaluated rTMS as a therapeutic tool for alcohol and drug use disorders; and 4) outline a conceptual framework for target selection when designing future rTMS clinical trials in substance use disorders. The manuscript concludes with some suggestions for methodological innovation, specifically with regard to combining rTMS with pharmacotherapy as well as cognitive behavioral training paradigms. We have attempted to create a comprehensive manuscript that provides the reader with a basic set of knowledge and an introduction to the primary experimental questions that will likely drive the field of TMS treatment development forward for the next several years. ER -